Q3 FY24 Financial Highlights

CAPITAL ALLOCATION PRIORITIES Strategic investments in sustainable and accretive growth 4.0x 3.5x Expected leverage of ~3.0x Net Debt/ Adjusted EBITDA in FY24** 3.0x 2.5x 2.0x 1.5x 1.0x 0.5x 0.0x FY17 FY18 FY19 FY20 FY21 Net Debt/ Adjusted EBITDA# FY22 FY 23 300% 250% 200% 150% Continue to target 100% FCF conversion** 100% Free Cash Flow conversion #+ (RHS) Balancing growth investing and current returns to shareholders on a solid financial foundation #Non-IFRS and other financial measures (See slides 37 - 41). Figures presented include both continuing and discontinued operations and have not been reclassified for the disposal of the Healthcare segment; +FCF conversion measured as a % of adjusted net income **Forward-Looking Statements (slides 2-3) 14 CAE Inc. Proprietary Information and/or Confidential 50% FY24 CAE

View entire presentation